Pharvaris (PHVS) News Today $18.48 +1.21 (+7.01%) As of 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Cantor Fitzgerald Initiates Coverage of Pharvaris N.V. (PHVS) with Overweight RecommendationApril 30 at 4:39 AM | msn.comPharvaris (NASDAQ:PHVS) Sees Unusually-High Trading Volume - Here's WhyPharvaris (NASDAQ:PHVS) Sees Strong Trading Volume - Still a Buy?April 27 at 12:16 PM | marketbeat.comRock Springs Capital Management LP Purchases 18,200 Shares of Pharvaris (NASDAQ:PHVS)Rock Springs Capital Management LP raised its position in shares of Pharvaris (NASDAQ:PHVS - Free Report) by 2.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 775,131 shares of the company's stock afApril 23, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Stock Price Up 7.8% - Still a Buy?Pharvaris (NASDAQ:PHVS) Trading Up 7.8% - Time to Buy?April 17, 2025 | marketbeat.comFmr LLC Has $103.43 Million Holdings in Pharvaris (NASDAQ:PHVS)Fmr LLC increased its position in Pharvaris (NASDAQ:PHVS - Free Report) by 3.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 5,395,370 shares of the company's stock after purchasing an additional 189,714 shares during the period. Fmr LLC owned about 10April 16, 2025 | marketbeat.comQ1 Earnings Estimate for Pharvaris Issued By Leerink PartnrsPharvaris (NASDAQ:PHVS - Free Report) - Analysts at Leerink Partnrs dropped their Q1 2025 EPS estimates for Pharvaris in a report released on Monday, April 7th. Leerink Partnrs analyst J. Schwartz now forecasts that the company will post earnings of ($0.91) per share for the quarter, down from thApril 12, 2025 | marketbeat.comWedbush Comments on Pharvaris' Q1 Earnings (NASDAQ:PHVS)Pharvaris (NASDAQ:PHVS - Free Report) - Analysts at Wedbush lowered their Q1 2025 EPS estimates for shares of Pharvaris in a research report issued to clients and investors on Monday, April 7th. Wedbush analyst L. Chico now forecasts that the company will post earnings of ($0.92) per share for thApril 12, 2025 | marketbeat.comWhat is Wedbush's Estimate for Pharvaris FY2029 Earnings?Pharvaris (NASDAQ:PHVS - Free Report) - Equities researchers at Wedbush issued their FY2029 EPS estimates for Pharvaris in a research note issued on Monday, April 7th. Wedbush analyst L. Chico forecasts that the company will post earnings of $5.99 per share for the year. The consensus estimate foApril 11, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Hits New 12-Month Low - Here's What HappenedPharvaris (NASDAQ:PHVS) Sets New 12-Month Low - Should You Sell?April 11, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Stock Price Down 8.4% - Here's What HappenedPharvaris (NASDAQ:PHVS) Stock Price Down 8.4% - Here's What HappenedApril 9, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Announces Quarterly Earnings Results, Beats Expectations By $0.06 EPSPharvaris (NASDAQ:PHVS - Get Free Report) released its quarterly earnings data on Monday. The company reported ($0.68) EPS for the quarter, beating analysts' consensus estimates of ($0.74) by $0.06.April 9, 2025 | marketbeat.comPharvaris reports Q4 EPS (EUR 0.64) vs. (EUR 0.95) last yearApril 8, 2025 | markets.businessinsider.comPharvaris Reports 2024 Financial Results and Business ProgressApril 8, 2025 | tipranks.comPharvaris Reports 2024 Financial Results and Advances HAE Treatment StudiesApril 7, 2025 | tipranks.comPharvaris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateApril 7, 2025 | gurufocus.comPharvaris Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateApril 7, 2025 | globenewswire.comPharvaris (NASDAQ:PHVS) Sets New 12-Month Low - Time to Sell?Pharvaris (NASDAQ:PHVS) Reaches New 12-Month Low - What's Next?April 5, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Sees Unusually-High Trading Volume - What's Next?Pharvaris (NASDAQ:PHVS) Sees Unusually-High Trading Volume - Here's What HappenedApril 4, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Stock Price Down 4.3% - What's Next?Pharvaris (NASDAQ:PHVS) Trading Down 4.3% - What's Next?April 3, 2025 | marketbeat.comPharvaris (PHVS) Projected to Post Earnings on WednesdayPharvaris (NASDAQ:PHVS) will be releasing earnings before the market opens on Wednesday, April 9, Financial Modeling Prep reports.April 3, 2025 | marketbeat.comPharvaris says EC grants orphan designation to deucrictibantApril 2, 2025 | markets.businessinsider.comPharvaris Announces Orphan Designation Granted to Deucrictibant by the European CommissionApril 1, 2025 | globenewswire.comPharvaris (NASDAQ:PHVS) Trading Up 6% - Still a Buy?Pharvaris (NASDAQ:PHVS) Trading 6% Higher - Here's What HappenedMarch 28, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Trading Up 5.5% - Should You Buy?Pharvaris (NASDAQ:PHVS) Shares Up 5.5% - Still a Buy?March 22, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Stock Price Down 3.2% - Time to Sell?Pharvaris (NASDAQ:PHVS) Trading Down 3.2% - Should You Sell?March 20, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Short Interest Up 24.7% in FebruaryPharvaris (NASDAQ:PHVS - Get Free Report) was the recipient of a significant growth in short interest in February. As of February 28th, there was short interest totalling 487,300 shares, a growth of 24.7% from the February 13th total of 390,900 shares. Based on an average trading volume of 55,500 shares, the days-to-cover ratio is currently 8.8 days. Approximately 2.8% of the company's stock are short sold.March 18, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Shares Gap Down - Should You Sell?Pharvaris (NASDAQ:PHVS) Shares Gap Down - Here's What HappenedMarch 18, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Trading 4.3% Higher - Still a Buy?Pharvaris (NASDAQ:PHVS) Trading 4.3% Higher - Here's What HappenedMarch 14, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Shares Gap Down - What's Next?Pharvaris (NASDAQ:PHVS) Shares Gap Down - Here's What HappenedMarch 12, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Shares Gap Up - Time to Buy?Pharvaris (NASDAQ:PHVS) Shares Gap Up - Should You Buy?March 11, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Short Interest UpdatePharvaris (NASDAQ:PHVS - Get Free Report) was the recipient of a large growth in short interest during the month of February. As of February 15th, there was short interest totalling 390,900 shares, a growth of 25.7% from the January 31st total of 311,100 shares. Approximately 2.3% of the company's shares are short sold. Based on an average daily volume of 64,900 shares, the short-interest ratio is currently 6.0 days.March 6, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Trading Down 5.7% - Here's WhyPharvaris (NASDAQ:PHVS) Shares Down 5.7% - Should You Sell?March 6, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Sets New 1-Year Low - Time to Sell?Pharvaris (NASDAQ:PHVS) Sets New 52-Week Low - Here's WhyMarch 6, 2025 | marketbeat.comPharvaris reports safety and efficacy data of deucrictibantMarch 3, 2025 | markets.businessinsider.comPharvaris Presents Long-Term Clinical Data of Deucrictibant for the Prevention and Treatment of HAE Attacks at the 2025 AAAAI/WAO Joint CongressMarch 3, 2025 | globenewswire.comPharvaris to Participate in the Leerink Partners Global Healthcare Conference 2025March 3, 2025 | globenewswire.comPharvaris (NASDAQ:PHVS) Hits New 12-Month Low - Should You Sell?Pharvaris (NASDAQ:PHVS) Sets New 1-Year Low - Time to Sell?February 27, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Sees Large Volume Increase - Still a Buy?Pharvaris (NASDAQ:PHVS) Sees Unusually-High Trading Volume - Should You Buy?February 24, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Sees Strong Trading Volume - What's Next?Pharvaris (NASDAQ:PHVS) Sees Unusually-High Trading Volume - What's Next?February 12, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Sees Unusually-High Trading Volume - Time to Buy?Pharvaris (NASDAQ:PHVS) Sees Large Volume Increase - Here's WhyFebruary 6, 2025 | marketbeat.comPharvaris price target raised to $55 from $46 at JMP SecuritiesJanuary 31, 2025 | markets.businessinsider.comJMP Securities Issues Positive Forecast for Pharvaris (NASDAQ:PHVS) Stock PriceJMP Securities lifted their price target on Pharvaris from $46.00 to $55.00 and gave the stock a "market outperform" rating in a research note on Friday.January 31, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Shares Gap Down - Here's What HappenedPharvaris (NASDAQ:PHVS) Shares Gap Down - What's Next?January 28, 2025 | marketbeat.comPharvaris FY2026 EPS Estimate Reduced by Leerink PartnrsPharvaris (NASDAQ:PHVS - Free Report) - Investment analysts at Leerink Partnrs dropped their FY2026 earnings per share estimates for Pharvaris in a report released on Monday, January 20th. Leerink Partnrs analyst J. Schwartz now expects that the company will post earnings of ($2.87) per share forJanuary 22, 2025 | marketbeat.comPharvaris (NASDAQ:PHVS) Shares Up 5.3% - Here's WhyPharvaris (NASDAQ:PHVS) Stock Price Up 5.3% - Here's WhyJanuary 21, 2025 | marketbeat.comBank of America Securities Sticks to Their Sell Rating for Pharvaris (PHVS)January 16, 2025 | markets.businessinsider.comPharvaris Positioned for Growth: Strategic Focus on Deucrictibant and Financial Stability Drive Buy RatingJanuary 15, 2025 | markets.businessinsider.comPharvaris (NASDAQ:PHVS) Shares Down 11.7% - Here's What HappenedPharvaris (NASDAQ:PHVS) Shares Down 11.7% - What's Next?January 13, 2025 | marketbeat.comPharvaris N.V.: Pharvaris Outlines 2025 Strategic PrioritiesJanuary 13, 2025 | finanznachrichten.dePharvaris Outlines 2025 Strategic PrioritiesJanuary 13, 2025 | globenewswire.com Get Pharvaris News Delivered to You Automatically Sign up to receive the latest news and ratings for PHVS and its competitors with MarketBeat's FREE daily newsletter. Email Address PHVS Media Mentions By Week PHVS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PHVS News Sentiment▼0.960.85▲Average Medical News Sentiment PHVS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PHVS Articles This Week▼42▲PHVS Articles Average Week Get Pharvaris News Delivered to You Automatically Sign up to receive the latest news and ratings for PHVS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Ultragenyx Pharmaceutical News Arcellx News SpringWorks Therapeutics News Organon & Co. News Merus News Crinetics Pharmaceuticals News Scholar Rock News Akero Therapeutics News Viking Therapeutics News Xenon Pharmaceuticals News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PHVS) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredTop performing AI play of the decade…? (The answer will shock you)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pharvaris Please log in to your account or sign up in order to add this asset to your watchlist. Share Pharvaris With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PHVS Stock Free PHVS Stock Alerts